In case of CHI caused by genetic defects in pancreatic transcription factors genes (HNF4A, HNF1A), it is essential to adjust the dose of diazoxide as HH in these cases is transient and subsides in childhood. Here, HNF4A is linked to congenital isolated hyperinsulinism.